TAVR Embolic Protection: A Safety Net in Need of More Data

The SENTINEL trial on embolic protection during transcatheter aortic valve replacement did not meet its primary endpoint, but Drs Mack and Jolly are not ready to rule out a benefit for the strategy.
Source: Medscape Cardiology Podcast - Category: Cardiology Authors: Source Type: podcasts